Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine ...